Literature DB >> 25641744

PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.

Long Zhang1, Wei You, Hanze Zhang, Rui Peng, Qin Zhu, Aihua Yao, Xiangcheng Li, Yebin Zhou, Xuehao Wang, Liyong Pu, Jindao Wu.   

Abstract

BACKGROUND AND AIM: One single-nucleotide polymorphisms (SNPs) rs738409 in the patatin-like phospholipase domain-containing 3 gene (PNPLA3) has been implicated in susceptibility to non-alcoholic fatty liver disease (NAFLD) across different populations. One meta-analysis confirmed this association, but within it, only two Asian studies were included. This meta-analysis aimed to investigate the association in Asian population.
METHODS: All eligible case-control studies were identified by searching through PubMed and Chinese language databases (CNKI and WanFang) up to July 1, 2014. Pooled estimates (odds ratio [OR] and standardized mean difference) were used to assess the strength of associations in fixed or random-effects models.
RESULTS: A total of 12 studies with 4495 cases and 7431 controls were included. SNP rs738409 G allele was confirmed as a risk factor for NAFLD (G allele vs C allele: OR = 1.92, 95% confidence interval [95%CI]: 1.54-2.39). In addition, based on studies with certain clinical measurements data, G allele carriers were more likely to have higher level of serum alanine aminotransferase (ALT) (standard mean difference [SMD] = 7.03, 95% CI: 2.47-11.60), and higher fibrosis score (SMD = 0.39, 95% CI: 0.18-0.60).
CONCLUSION: This study provided evidence of SNP rs738409 G allele as a strong risk factor of NAFLD susceptibility and higher level of serum ALT in Asian population.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  ALT; Asian population; NAFLD; PNPLA3; meta-analysis

Mesh:

Substances:

Year:  2015        PMID: 25641744     DOI: 10.1111/jgh.12889

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  25 in total

1.  Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.

Authors:  Shahinul Alam; Mohammad Shaiful Islam; Saiful Islam; Golam Mustafa; Ahmed Abu Saleh; Nooruddin Ahmad
Journal:  Indian J Gastroenterol       Date:  2017-10-04

2.  Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

Authors:  Kentaro Oniki; Junji Saruwatari; Tomoko Izuka; Ayami Kajiwara; Kazunori Morita; Misaki Sakata; Koji Otake; Yasuhiro Ogata; Kazuko Nakagawa
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

Review 3.  Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review.

Authors:  Elina M Petäjä; Hannele Yki-Järvinen
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

4.  PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum.

Authors:  Habeeb Salameh; Muhannad Al Hanayneh; Maen Masadeh; Mohammed Naseemuddin; Tasnia Matin; Angelika Erwin; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2016-07-08

5.  PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease.

Authors:  Habeeb Salameh; Maen Masadeh; Muhannad Al Hanayneh; Vincent Petros; Matthew Maslonka; Arjun Nanda; Ashwani K Singal
Journal:  World J Hepatol       Date:  2016-12-18

6.  Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.

Authors:  Chao-Min Huang; Kuo-Chin Chang; Chao-Hung Hung; King-Wah Chiu; Sheng-Nan Lu; Jing-Houng Wang; Chien-Hung Chen; Kwong-Ming Kee; Yuan-Hung Kuo; Ming-Chao Tsai; Po-Lin Tseng; Ming-Tsung Lin; Cheng-Kun Wu; Tsung-Hui Hu; Chung-Lung Cho; Yi-Hao Yen
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

7.  Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations.

Authors:  Ana Cecilia Pontoriero; Julieta Trinks; María Laura Hulaniuk; Mariela Caputo; Lisandro Fortuny; Leandro Burgos Pratx; Analía Frías; Oscar Torres; Félix Nuñez; Adrián Gadano; Pablo Argibay; Daniel Corach; Diego Flichman
Journal:  BMC Genet       Date:  2015-07-29       Impact factor: 2.797

Review 8.  Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.

Authors:  Hannele Yki-Järvinen
Journal:  Nutrients       Date:  2015-11-05       Impact factor: 5.717

9.  PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.

Authors:  Gemma Aragonès; Teresa Auguet; Sandra Armengol; Alba Berlanga; Esther Guiu-Jurado; Carmen Aguilar; Salomé Martínez; Fátima Sabench; José Antonio Porras; Maikel Daniel Ruiz; Mercé Hernández; Joan Josep Sirvent; Daniel Del Castillo; Cristóbal Richart
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

10.  Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Nader Salari; Niloufar Darvishi; Kamran Mansouri; Hooman Ghasemi; Melika Hosseinian-Far; Fateme Darvishi; Masoud Mohammadi
Journal:  BMC Endocr Disord       Date:  2021-06-19       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.